†
147
HR 2862 EAS
shall not otherwise be required to meet the meet the storage,
reporting, recordkeeping, or physical security control re-
quirements (such as a cage or vault) for controlled sub-
stances in schedule V containing pseudoephedrine or ephed-
rine.
(e) STATE PENALTIES AND PEDIATRIC PRODUCTS.—
Nothing in this Act shall be construed to—
(1) prevent a State or political subdivision of a
State from adopting and enforcing penalties that are
different from, in addition to, or otherwise not iden-
tical with, the penalties that apply under the Con-
trolled Substances Act (28 U.S.C. 801 et seq.); or
(2) prevent a State or political subdivision of a
State from permitting the sale of pediatric products
containing pseudoephedrine or ephedrine, their salts
or optical isomers, or salts of optical isomers where
the pediatric product—
(A) is primarily intended for administra-
tion, according to label instructions, to children
under 12 years of age and either—
(i) in solid dosage form, individual
dosage units do not exceed 15 milligrams of
ephedrine or pseudoephedrine; or
(ii) in liquid form, recommended dos-
age units, according to label instructions, do
†
148
HR 2862 EAS
not exceed 15 milligrams of ephedrine or
pseudoephedrine per 5 milliliters of liquid
product; or
(B) is in liquid form—
(i) primarily intended for administra-
tion to children under 2 years of age;
(ii) the recommended dosage of which
does not exceed 2 milliliters; and
(iii) the total package content is not
more than 1 fluid ounce.
(f) EFFECTIVE DATES.—
(1) ONLY ACTIVE INGREDIENT.—This section and
the amendments made by this section shall take effect
with regard to any substance in which ephedrine or
pseudoephedrine is the only active ingredient 90 days
after the date of enactment of this Act.
(2) OTHER
PRODUCTS.—This section and the
amendments made by this section shall take effect
with regard to any substance other than a substance
described in paragraph (1) on January 1, 2007.
SEC. 711. EMPLOYER SCREENING OF EMPLOYEES WORKING
WITH CONTROLLED SUBSTANCES.
Part C of the Controlled Substances Act (21 U.S.C.
821 et seq.) is amended by adding at the end the following:
†
149
HR 2862 EAS
‘‘APPLICANTS AND EMPLOYEES
‘‘SEC. 311. Persons registered with the Drug Enforce-
ment Administration to manufacture, deliver, distribute, or
dispense controlled substances shall take reasonable steps to
guard against hiring persons who may, as a result of their
employment, have access to and become involved in the theft
and diversion of controlled substances, including, notwith-
standing State law, asking applicants for employment
whether they have been convicted of any crime involving
or related to controlled substances.’’.
Subtitle B—Education, Prevention,
and Treatment
SEC. 721. GRANTS FOR SERVICES FOR CHILDREN OF SUB-
STANCE ABUSERS.
Section 519 of the Public Health Service Act (42
U.S.C. 290bb–25) is amended—
(1) in subsection (b), by inserting after para-
graph (8) the following:
‘‘(9) Development of drug endangered children
rapid response teams that will intervene on behalf of
children exposed to methamphetamine as a result of
residing or being present in a home-based clandestine
drug laboratory.’’; and
(2) in subsection (o)—
†
150
HR 2862 EAS
(A) by striking ‘‘For the purpose’’ and in-
serting the following:
‘‘(1) IN GENERAL.—For the purpose’’; and
(B) by adding at the end the following:
‘‘(2) DRUG ENDANGERED CHILDREN RAPID RE-
SPONSE TEAMS.—There are authorized to be appro-
priated $2,500,000 for each of the fiscal years 2006
and 2007 to carry out the provisions of subsection
(b)(9).’’.
SEC. 722. LOCAL GRANTS FOR TREATMENT OF METH-
AMPHETAMINE ABUSE AND RELATED CONDI-
TIONS.
Subpart 1 of part B of title V of the Public Health
Service Act (42 U.S.C. 290bb et seq.) is amended—
(1) by redesignating section 514 that relates to
methamphetamine and appears after section 514A as
section 514B;
(2) in section 514B, as redesignated—
(A) by amending subsection (a)(1) to read
as follows:
‘‘(1) GRANTS AUTHORIZED.—The Secretary may
award grants to States, political subdivisions of
States, American Indian Tribes, and private, non-
profit entities to provide treatment for methamphet-
amine abuse.’’;
†
151
HR 2862 EAS
(B) by amending subsection (b) to read as
follows:
‘‘(b) PRIORITY FOR HIGH NEED STATES.—In award-
ing grants under subsection (a), the Secretary shall give
priority to entities that will serve rural or urban areas ex-
periencing an increase in methamphetamine abuse in
States with addiction rates in excess of the national rate.’’;
and
(C) in subsection (d)(1), by striking ‘‘2000’’
and all that follows and inserting ‘‘2005 and
such sums as may be necessary for each of fiscal
years 2006 through 2009’’; and
(3) by inserting after section 514B, as redesig-
nated, the following:
‘‘SEC. 514C. METHAMPHETAMINE RESEARCH, TRAINING,
AND TECHNICAL ASSISTANCE CENTER.
‘‘(a) PROGRAM AUTHORIZED.—The Secretary, acting
through the Administrator, and in consultation with the
Director of the National Institutes of Health, shall award
grants to, or enter into contracts with, public or private,
nonprofit entities to establish a research, training, and tech-
nical assistance center to carry out the activities described
in subsection (d).
‘‘(b) APPLICATION.—A public or private, nonprofit en-
tity seeking a grant or contract under subsection (a) shall
†
152
HR 2862 EAS
submit an application to the Secretary at such time, in
such manner, and containing such information as the Sec-
retary may require.
‘‘(c) CONDITION.—In awarding grants or entering into
contracts under subsection (a), the Secretary shall ensure
that not less than 1 of the centers will focus on methamphet-
amine abuse in rural areas.
‘‘(d) AUTHORIZED ACTIVITIES.—Each center estab-
lished under this section shall—
‘‘(1) engage in research and evaluation of the ef-
fectiveness of treatment modalities for the treatment of
methamphetamine abuse;
‘‘(2) disseminate information to public and pri-
vate entities on effective treatments for methamphet-
amine abuse;
‘‘(3) provide direct technical assistance to States,
political subdivisions of States, and private entities
on how to improve the treatment of methamphetamine
abuse; and
‘‘(4) provide training on the effects of meth-
amphetamine use and on effective ways of treating
methamphetamine abuse to substance abuse treatment
professionals and community leaders.